Results 181 to 190 of about 113,885,625 (237)

Identifying Systemic Lupus Erythematosus From Serum Proteomic Profiles Using Machine Learning and Genetic Risk Stratification

open access: yesArthritis &Rheumatology, Volume 78, Issue 11, Page 2280-2291, November 2026.
Objective Proteome‐wide risk models for lupus remain underexplored. We developed classification models to identify lupus from serum proteomic profiles. Methods Patients with lupus and individuals with other autoimmune diseases in the UK Biobank were included.
Mehmet Hocaoǧlu   +2 more
wiley   +1 more source

New therapeutic options for metabolic‐associated steatotic liver disease

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3770-3777, November 2026.
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley   +1 more source

Curcumin Intervention in Diabetic Neuropathy: Molecular Mechanisms and Preclinical Insights

open access: yesChemistry &Biodiversity, Volume 23, Issue 11, November 2026.
This review highlights curcumin's neuroprotective potential, showing how it mitigates oxidative stress and inflammation by modulating Nrf2, MAPK, and NF‐κB signaling. Preclinical data shows it stabilizes glucose metabolism and reduces nerve degradation.
Sanket Sharma   +5 more
wiley   +1 more source

Comparison of Serum Uric Acid and Serum Uric Acid‐to‐Creatinine Ratio as Indicators of Metabolic Syndrome: A Cross‐Sectional Study in China

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
Serum uric acid and its ratio to creatinine are both valuable predictors for the early prevention, diagnosis and treatment of metabolic syndrome in routine clinical practice. ABSTRACT Objective This study aimed to systematically compare the roles of both serum uric acid (SUA) and Serum uric acid to creatine ratio (SUACr) as indicators of metabolic ...
Qiang Wang   +7 more
wiley   +1 more source

Comparative Efficacy and Safety of Saroglitazar and Dapagliflozin on Hepatic Steatosis and Glycemic Control in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A 25‐Week Prospective Multicenter Comparative Cohort Study

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
In this 25‐week, non‐randomized comparative cohort study of 54 adults with MASLD and type 2 diabetes, saroglitazar and dapagliflozin both reduced hepatic steatosis, with no significant between‐group difference in steatosis or liver stiffness. Saroglitazar achieved a significantly greater HbA1c reduction, and no treatment‐emergent adverse events ...
Mukulesh Gupta   +6 more
wiley   +1 more source

Biological activities and bioactive constituents of Flammulina velutipes: An updated systematic review

open access: yesJournal of the Science of Food and Agriculture, Volume 106, Issue 14, Page 8298-8314, November 2026.
Abstract Flammulina velutipes (enokitake) is an edible mushroom recognized for both its nutritional and medicinal properties. It exhibits a broad spectrum of biological activities, including antioxidant, anti‐inflammatory, antitumor, immunomodulatory, and gut microbiota‐regulating effects.
Rıdvan Özgen   +2 more
wiley   +1 more source

Short‐ and Long‐Term Control of Hypertension After Bariatric Surgery: A 10‐Year Prospective Study

open access: yesMedComm, Volume 7, Issue 11, November 2026.
ABSTRACT Current guidelines support bariatric surgery (BS) as an effective treatment mainly for patients with severe obesity and poorly controlled hypertension. However, evidence in non‐severely obese Asian populations remains limited. This multicenter prospective cohort study included 248 Chinese patients with obesity and hypertension who underwent BS
Xiaoxiao Zhong   +10 more
wiley   +1 more source

Liver Injury Repair and Regeneration: Molecular Mechanisms and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 11, November 2026.
This review outlines the spatiotemporal framework of liver injury repair and regeneration, orchestrated by molecular signaling, multicellular niche crosstalk, metabolic reprogramming, and interorgan communication. Post‑injury regenerative cascades (initiation, proliferation, termination) rely on crosstalk between hepatocytes, Kupffer cells, hepatic ...
Mingyue Pan   +15 more
wiley   +1 more source

Pharmacological and Therapeutic Potential of Garlic (Allium sativum): Integrating Phytochemistry, Molecular Mechanisms, and Clinical and Preclinical Evidence

open access: yesChemistryOpen, Volume 15, Issue 11, November 2026.
Garlic bioactive compounds, including organosulfur compounds (allicin, DADS, DATS, and SAC), phenolic compounds, and quercetin, regulate the Nrf2/HO‐1, NF‐κB, PI3K/Akt, and AMPK/eNOS signaling pathways. These actions enhance antioxidant defenses, suppress inflammation, improve metabolic and cardiovascular function, and contribute to reduced blood ...
Gudisa Bereda
wiley   +1 more source

Anti‐TNF Therapy Is Associated With Browning‐ and Immune‐Related Changes in Creeping Fat in Crohn's Disease

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 9, November 2026.
ABSTRACT Background Creeping fat (CrF) in Crohn's disease (CD) is a metabolically active perilesional adipose tissue involved in intestinal inflammation. Whether biological therapies modify its browning‐associated phenotype remains largely unexplored.
Diandra Monfort‐Ferré   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy